These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 30344785

  • 21. A study to standardize quantitative evaluation of parotid gland scintigraphy in patients with Sjögren's syndrome.
    Nishiyama S, Miyawaki S, Yoshinaga Y.
    J Rheumatol; 2006 Dec; 33(12):2470-4. PubMed ID: 17143981
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Sjögren's syndrome: comparison of assessments with quantitative salivary gland scintigraphy and contrast sialography.
    Aung W, Yamada I, Umehara I, Ohbayashi N, Yoshino N, Shibuya H.
    J Nucl Med; 2000 Feb; 41(2):257-62. PubMed ID: 10688108
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Quantitative analysis for modified Schall's classification by stimulation test with dynamic scintigraphy in Sjögren's syndrome.
    Zhu GW, Gao Z, Feng HB, Qiu JJ.
    Int J Rheum Dis; 2020 Mar; 23(3):381-391. PubMed ID: 31863640
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Sialocintigraphy versus ultrasonography of the salivary glands in patients first diagnosed with Sjögren's syndrome.
    Decuzzi M, Tatulli F, Giampaolo M, Tesse R, Gasparre M, Pepe G, Decuzzi P, Asteriadis I.
    Hell J Nucl Med; 2006 Mar; 9(2):103-5. PubMed ID: 16894414
    [Abstract] [Full Text] [Related]

  • 28. Normal values of [99mTc]pertechnetate uptake and excretion fraction by major salivary glands.
    Anjos DA, Etchebehere EC, Santos AO, Lima MC, Ramos CD, Paula RB, Camargo EE.
    Nucl Med Commun; 2006 Apr; 27(4):395-403. PubMed ID: 16531928
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Decreased thyroid uptake of Tc-99m pertechnetate in patients with advanced-stage Sjögren syndrome: evaluation using salivary gland scintigraphy.
    Taura S, Murata Y, Aung W, Ishida R, Zhang L, Hossain M, Takahashi Y, Okada N, Shibuya H.
    Clin Nucl Med; 2002 Apr; 27(4):265-9. PubMed ID: 11914666
    [Abstract] [Full Text] [Related]

  • 31. Semi-quantitative analysis of salivary gland scintigraphy in Sjögren's syndrome diagnosis: a first-line tool.
    Angusti T, Pilati E, Parente A, Carignola R, Manfredi M, Cauda S, Pizzigati E, Dubreuil J, Giammarile F, Podio V, Skanjeti A.
    Clin Oral Investig; 2017 Sep; 21(7):2389-2395. PubMed ID: 28050735
    [Abstract] [Full Text] [Related]

  • 32. Clinical significance and diagnostic usefulness of anti-centromere antibody in Sjögren's syndrome.
    Kitagawa T, Shibasaki K, Toya S.
    Clin Rheumatol; 2012 Jan; 31(1):105-12. PubMed ID: 21670951
    [Abstract] [Full Text] [Related]

  • 33. Salivary gland scintigraphy in Sjögren's syndrome: are quantitative indices the answer?
    Adams BK, Al Attia HM, Parkar S.
    Nucl Med Commun; 2003 Sep; 24(9):1011-6. PubMed ID: 12960601
    [Abstract] [Full Text] [Related]

  • 34. Oral pilocarpine HCl stimulates labial (minor) salivary gland flow in patients with Sjögren's syndrome.
    Rhodus NL.
    Oral Dis; 1997 Jun; 3(2):93-8. PubMed ID: 9467349
    [Abstract] [Full Text] [Related]

  • 35. Application of the OMERACT Grey-scale Ultrasound Scoring System for salivary glands in a single-centre cohort of patients with suspected Sjögren's syndrome.
    Fana V, Dohn UM, Krabbe S, Terslev L.
    RMD Open; 2021 Apr; 7(2):. PubMed ID: 33879581
    [Abstract] [Full Text] [Related]

  • 36. Distribution and dynamics of (99m)Tc-pertechnetate uptake in the thyroid and other organs assessed by single-photon emission computed tomography in living mice.
    Franken PR, Guglielmi J, Vanhove C, Koulibaly M, Defrise M, Darcourt J, Pourcher T.
    Thyroid; 2010 May; 20(5):519-26. PubMed ID: 20384490
    [Abstract] [Full Text] [Related]

  • 37. Value of quantitative salivary gland scintigraphy in the early stage of Sjögren's syndrome.
    Bohuslavizki KH, Brenner W, Wolf H, Sippel C, Tönshoff G, Tinnemeyer S, Clausen M, Henze E.
    Nucl Med Commun; 1995 Nov; 16(11):917-22. PubMed ID: 8587757
    [Abstract] [Full Text] [Related]

  • 38. Quantitative evaluation of salivary gland scintigraphy in Sjörgen's syndrome.
    Umehara I, Yamada I, Murata Y, Takahashi Y, Okada N, Shibuya H.
    J Nucl Med; 1999 Jan; 40(1):64-9. PubMed ID: 9935059
    [Abstract] [Full Text] [Related]

  • 39. Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjögren's syndrome (SS), with an emphasis on sonography.
    Shimizu M, Okamura K, Kise Y, Takeshita Y, Furuhashi H, Weerawanich W, Moriyama M, Ohyama Y, Furukawa S, Nakamura S, Yoshiura K.
    Arthritis Res Ther; 2015 Aug 23; 17(1):223. PubMed ID: 26298875
    [Abstract] [Full Text] [Related]

  • 40. Utility of Quantitative Parameters from Single-Photon Emission Computed Tomography/Computed Tomography in Patients with Destructive Thyroiditis.
    Kim JY, Kim JH, Moon JH, Kim KM, Oh TJ, Lee DH, So Y, Lee WW.
    Korean J Radiol; 2018 Aug 23; 19(3):470-480. PubMed ID: 29713225
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.